| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $19.0M | -52.2% |
| R&D Expense | $17.7M | +23.0% |
| SG&A Expense | $12.0M | +64.5% |
| Operating Income | -$10.6M | -158.0% |
| Interest Expense | $0 | -100.0% |
| Pre-tax Income | -$10.0M | -154.8% |
| Income Tax | $12K | -96.2% |
| Net Income | -$10.0M | -155.8% |
| EPS (Basic) | -$0.46 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $50.5M | +18.5% |
| Short-term Investments | $15K | -69.4% |
| Accounts Receivable | $926K | -28.7% |
| Current Assets | $53.9M | +10.1% |
| Total Assets | $53.9M | +10.1% |
| Current Liabilities | $4.0M | +46.8% |
| Total Liabilities | $4.0M | +46.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.1M | -107.8% |
| Investing Cash Flow | $0 | — |
| Financing Cash Flow | $9.0M | +137.2% |
| -151.1% |
| EPS (Diluted) | -$0.46 | -152.9% |
| Stockholders' Equity |
| $49.9M |
| +7.9% |